News & Updates
Filter by Specialty:
Steroid-free remission in Crohn’s disease does not equate to less progression
For Crohn’s disease patients, achieving a complete and sustained clinical remission off steroids does not necessarily translate to a lower likelihood of experiencing progression, according to data from the TAILORIX trial.
Steroid-free remission in Crohn’s disease does not equate to less progression
03 Dec 2021
Milvexian prevents VTE after knee arthroplasty, bleeding risk low
Postoperative treatment with the oral factor XIa inhibitor milvexian could help prevent the incidence of venous thromboembolism (VTE) in patients undergoing elective knee arthroplasty, according to results of a phase II trial presented at AHA 2021.
Milvexian prevents VTE after knee arthroplasty, bleeding risk low
02 Dec 2021
Two-dose hep-B vaccine more seroprotective than three-dose regimen in chronic liver disease patients
In a pooled post hoc analysis of three phase III trials, a novel two-dose hepatitis B (hep-B) vaccine regimen trumped the traditional three-dose regimen in inducing seroprotection in patients with chronic liver disease (CLD).
Two-dose hep-B vaccine more seroprotective than three-dose regimen in chronic liver disease patients
02 Dec 2021
Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.
